W. Anthony Vernon

Director at Nuvation Bio

Mr. Vernon previously served as Chief Executive Officer of Kraft Foods Group, Inc., from 2012 until December 2014, and as President, Kraft Foods North America from 2009 to 2012. He also served as a senior advisors to the Board of Directors of Kraft Foods Group, Inc. until May 2015. Prior to joining Kraft, he was the healthcare industry partner of Ripplewood Holdings LLC, a private equity firm. Mr. Vernon spent 23 years at Johnson & Johnson where he ran independent business units and led several successful consumer brands. He currently serves as a Director on the Boards of Intersect ENT, Inc., NovoCure Limited, McCormick and Co., and on the Global Advisory Board of Northwestern University’s Kellogg School of Management. He previously served as a Director of Medivation, Inc., until its acquisition by Pfizer in 2016.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Nuvation Bio

2 followers

Nuvation Bio (NYSE: NUVB) is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.


Industries

Employees

11-50

Links